Innovus PharmaceuticalsINNV 
$5.990.67%24h
0.67%24h
Global rank8790
Market cap$812.21M
Change 7d-5.37%
YTD Performance0.00%
SP500 benchmarkUnderperform
P/E-19.97
P/S1.18
Revenue$688.09M
Earnings-$43.55M
Dividend yield-
Main Sector
Healthcare
Innovus Pharmaceuticals (INNV) Total Liabilities
INNV Total Liabilities in 2022: $252.56M
According to Innovus Pharmaceuticals latest financial reports the total liabilities of INNV is $252.56M, an increase of 25.12% to 2022. At the end of 2022 company had $201.85M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Innovus Pharmaceuticals is responsible for during its operational activities.
Innovus Pharmaceuticals (INNV) Total Liabilities History from 2023 to 2022
-
Value:-
INNV Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $252.56M | 25.12% |
| 2022 | $201.85M | 16.15% |
| 2021 | $173.79M | -42.43% |
| 2020 | $301.88M | 18.24% |
| 2019 | $255.32M | - |
View the Top Total Liabilies Stocks
